Home/Filings/4/0001144204-17-015094
4//SEC Filing

Biostage, Inc. 4

Accession 0001144204-17-015094

$HRGNCIK 0001563665operating

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 4:16 PM ET

Size

8.0 KB

Accession

0001144204-17-015094

Insider Transaction Report

Form 4
Period: 2017-03-14
Transactions
  • Award

    Restricted Stock Units

    2017-03-14+18,25018,250 total
    Common Stock, par value $0.01 per share (18,250 underlying)
  • Award

    Stock Option (right to buy)

    2017-03-14+25,00025,000 total
    Exercise: $0.38Exp: 2027-03-14Common Stock, par value $0.01 per share (25,000 underlying)
Footnotes (3)
  • [F1]The option shares vest in full one year from the date of grant.
  • [F2]Restricted stock units granted by the Issuer pursuant to its 2013 Equity Incentive Plan and qualified under Rule 16b-3(d). Each restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer.
  • [F3]The restricted stock units vest and settle in full one year from the date of grant.

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001563665

Filing Metadata

Form type
4
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:16 PM ET
Size
8.0 KB